BED BATH & BEYOND, INC.
For the period ended Mar 31, 2026. Filed Apr 27, 2026.
View on SEC.govAbout this filing
A company's report for each of its first three quarters. The financial statements are not audited. It shows how the business has moved since the last annual report, and what management says changed.
Mar 31, 2026 · Filed Apr 27, 2026
NXH$1.36-9.9%Stored close · as of Nov 10, 2026
Extracted filing text, with the paragraph anchors used by the comparison.
See the whole filing, with its images and exhibitsContents
Consolidated Statements of Cash Flows
| Bed Bath & Beyond, Inc.Consolidated Statements of Cash Flows (Unaudited)(in thousands) | ||
|---|---|---|
| Three months endedMarch 31, | ||
| 2026 | 2025 | |
| Cash flows from operating activities: | ||
| Net loss | $(16,398) | $(39,912) |
| Adjustments to reconcile net loss to net cash used in operating activities: | ||
| Depreciation and amortization | 3,204 | 4,844 |
| Non-cash operating lease cost | 219 | 727 |
| Stock-based compensation to employees and directors | 1,533 | 1,094 |
| Loss from equity method securities | 2,405 | 17,073 |
| Other non-cash adjustments | (3,055) | (136) |
| Changes in operating assets and liabilities: | ||
| Accounts receivable, net | (3,176) | (2,225) |
| Inventories | 4,666 | (13,042) |
| Prepaids and other current assets | 2,518 | 2,167 |
| Other long-term assets, net | 22 | (125) |
| Accounts payable | 640 | (4,087) |
| Accrued liabilities | (3,810) | (14,302) |
| Unearned revenue | 210 | (2,288) |
| Operating lease liabilities | (221) | (662) |
| Other long-term liabilities | (553) | (47) |
| Net cash used in operating activities | (11,796) | (50,921) |
| Cash flows from investing activities: | ||
| Disbursement for notes receivable | (26,168) | — |
| Expenditures for property and equipment | (1,027) | (1,181) |
| Purchase of intangible assets | (100) | (5,214) |
| Purchase of equity securities | — | (8,000) |
| Proceeds from the sale of intangible assets | — | 1,250 |
| Net cash used in investing activities | (27,295) | (13,145) |
| Cash flows from financing activities: | ||
| Proceeds from sale of common stock, net of offering costs | — | 19,472 |
| Payments of taxes withheld upon vesting of employee stock awards | (980) | (527) |
| Other financing activities, net | 354 | 509 |
| Net cash (used in) provided by financing activities | (626) | 19,454 |
| Net decrease in cash, cash equivalents, and restricted cash | (39,717) | (44,612) |
| Cash, cash equivalents, and restricted cash, beginning of period | 202,219 | 186,093 |
| Cash, cash equivalents, and restricted cash, end of period | $162,502 | $141,481 |
The text of this filing, as the company filed it with the SEC, without its images or exhibits. This is not investment advice.